Taking Tylenol (acetaminophen) during pregnancy has not been proven to cause autism. Multiple studies have found a statistical association between prenatal acetaminophen use and higher rates of autism and ADHD in children, but a causal link has never been established. The FDA acknowledged this distinction in a 2024 notice to physicians, stating that “while an association between acetaminophen and autism has been described in many studies, a causal relationship has not been established and there are contrary studies in the scientific literature.”
That said, the picture is more complicated than a simple “no.” The volume of research raising questions has been enough for the FDA to recommend that clinicians consider minimizing acetaminophen use during pregnancy for routine low-grade fevers, and for 91 scientists and clinicians worldwide to sign a consensus statement urging caution. Here’s what the evidence actually shows and what it means for you.
What the Studies Found
Several large observational studies over the past decade have reported that children whose mothers used acetaminophen during pregnancy were diagnosed with autism or ADHD at somewhat higher rates than children whose mothers did not. Some of these studies found what researchers call a dose-response pattern: the more acetaminophen a mother used, the stronger the association appeared. Chronic use throughout pregnancy seemed to carry the most pronounced signal.
However, a major 2024 study published in JAMA used sibling comparisons to test whether the link held up under tighter scrutiny. Sibling studies are powerful because they naturally control for genetics, household environment, and many other shared factors that could skew results. When the researchers compared siblings born to the same mother (where one pregnancy involved more acetaminophen than the other), the association disappeared entirely. The researchers concluded that “shared familial confounders were involved,” meaning something about the families themselves, not the medication, likely explained the pattern.
This is a critical finding. It suggests that the mothers who take more acetaminophen may share characteristics (genetic predispositions, underlying health conditions, higher rates of infection or pain during pregnancy) that independently raise the likelihood of neurodevelopmental differences in their children.
Why Proving Cause Is So Difficult
Almost all the research on this topic is observational, meaning researchers track what people did and what happened afterward rather than randomly assigning some pregnant women to take acetaminophen and others to take a placebo. Observational studies can identify patterns, but they can’t prove one thing caused another. A classic example: people who carry lighters are more likely to develop lung cancer, but lighters don’t cause cancer. Smoking is the hidden variable connecting both.
In the case of acetaminophen, several hidden variables could be at play. Women who take more acetaminophen during pregnancy tend to have more infections, more pain, and more inflammation. Maternal fever itself is a known risk to fetal brain development, associated with miscarriage, preterm birth, and congenital differences. So the very conditions prompting a woman to reach for Tylenol could be the actual source of risk, not the drug.
There are also practical measurement problems. Most studies rely on women remembering their medication use months or years later, or on prescription records that don’t confirm whether the pills were actually taken. Without precise data on dose, frequency, and timing, it’s nearly impossible to distinguish between someone who took a single pill once and someone who used it daily for weeks.
How Acetaminophen Affects a Developing Fetus
Acetaminophen does cross the placenta and the fetal blood-brain barrier, which means it reaches the developing brain directly. Researchers have proposed several biological pathways through which it could theoretically affect neurodevelopment, even if none has been confirmed in humans.
The leading hypothesis involves oxidative stress. When your body breaks down acetaminophen, it produces a toxic byproduct that is normally neutralized by an antioxidant called glutathione. During pregnancy, when oxidative stress is already elevated, there may be less glutathione available to handle this byproduct. Studies of umbilical cord blood have found that higher levels of unmetabolized acetaminophen corresponded with markers of increased oxidative stress. Oxidative stress, in turn, can interfere with the function of brain cells that maintain and support developing neurons.
Animal studies have also suggested that acetaminophen may disrupt hormonal pathways important for fetal development and alter DNA methylation patterns, which are chemical modifications that influence how genes are expressed. Changes in methylation have been found in children diagnosed with ADHD who experienced long-term prenatal acetaminophen exposure. These mechanisms are plausible but remain far from proven as a pathway to autism in humans.
What the FDA and Medical Groups Recommend
Despite the uncertainty, the FDA’s 2024 notice to physicians struck a careful balance. It recommended that clinicians “consider minimizing the use of acetaminophen during pregnancy for routine low-grade fevers” while also emphasizing that acetaminophen remains “the safest over-the-counter alternative in pregnancy among all analgesics and antipyretics.” Aspirin and ibuprofen both carry well-documented risks to the fetus, including premature closure of a critical blood vessel and constriction of uterine arteries, particularly in the third trimester.
A 2021 international consensus statement, signed by 91 scientists and clinicians, recommended that pregnant women use the lowest effective dose for the shortest possible time, avoid using it unless medically indicated, and consult a physician or pharmacist before long-term use. This is a precautionary stance, not a conclusion that harm has been proven.
The Risk of Avoiding It Entirely
One point that often gets lost in the headlines: avoiding acetaminophen isn’t risk-free either. Untreated maternal fever has been linked to miscarriage, preterm birth, and congenital differences. Untreated pain can increase stress hormones that also affect fetal development. A systematic review published in The Lancet noted that “avoiding paracetamol based on inconclusive or biased evidence might increase the risk of maternal fever or untreated pain, both of which can harm pregnancy outcomes.”
This is the core tension. Acetaminophen is the only widely available over-the-counter pain and fever reducer considered appropriate during pregnancy. Refusing it entirely could leave you and your baby exposed to the very conditions it’s meant to treat.
Non-Drug Options for Pain During Pregnancy
For pain that doesn’t involve fever (particularly back pain, which affects a large percentage of pregnancies), non-drug approaches can reduce your need for acetaminophen without leaving you suffering. Physical therapy focusing on pelvic tilts, stretching, back strengthening, and Kegel exercises has strong evidence for relieving pregnancy-related back pain. Acupuncture has been studied during pregnancy and is generally considered safe, with some research suggesting it outperforms physical therapy for pain relief and reducing disability.
Water therapy, stabilization belts, yoga, and manual therapy techniques have also shown benefits. One randomized trial found that osteopathic treatment during the third trimester slowed or stopped the worsening of back-related pain and dysfunction compared to standard care alone. Nerve stimulation therapy (TENS) improved low back pain more effectively than exercise and acetaminophen combined in one study, though researchers noted those results need further confirmation.
For fever or significant pain where medication is genuinely needed, the current medical guidance is straightforward: acetaminophen at the lowest dose that works, for as few days as possible. That approach balances the theoretical concerns raised by research with the real and documented risks of leaving fever and severe pain untreated.
The Lawsuits and What They Mean
You may have seen ads about Tylenol autism lawsuits. Thousands of families have filed claims against acetaminophen manufacturers and retailers, consolidated into a federal case in New York (MDL 3043). However, in December 2023 and again in July 2024, the presiding judge excluded the plaintiffs’ expert testimony on causation, finding that the scientific evidence was not reliable enough to present to a jury. Without admissible expert opinions establishing that acetaminophen causes autism, these cases face significant legal hurdles. The lawsuits reflect genuine parental concern, but the court rulings underscore the same gap the FDA identified: association has been observed, but causation has not been proven.